Los Angeles Capital Management LLC Lowers Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Los Angeles Capital Management LLC reduced its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 9.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,174 shares of the company’s stock after selling 1,950 shares during the period. Los Angeles Capital Management LLC’s holdings in Surgery Partners were worth $456,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in Surgery Partners by 3.7% in the 4th quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock worth $266,098,000 after purchasing an additional 295,476 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Surgery Partners by 0.8% during the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock valued at $223,099,000 after buying an additional 61,400 shares during the last quarter. Clearbridge Investments LLC grew its holdings in shares of Surgery Partners by 4.7% during the fourth quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock valued at $176,766,000 after buying an additional 247,762 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of Surgery Partners by 7,987.1% during the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after acquiring an additional 2,473,282 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Surgery Partners by 8.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,840,212 shares of the company’s stock worth $58,870,000 after acquiring an additional 149,146 shares during the last quarter.

Analysts Set New Price Targets

A number of research firms have commented on SGRY. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Citigroup decreased their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Benchmark reissued a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Monday, August 26th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a report on Wednesday, August 7th. Finally, Macquarie assumed coverage on Surgery Partners in a report on Friday, June 28th. They set an “outperform” rating and a $31.00 price target for the company. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $39.86.

Surgery Partners Trading Up 3.5 %

Shares of Surgery Partners stock opened at $31.00 on Friday. Surgery Partners, Inc. has a twelve month low of $22.05 and a twelve month high of $36.92. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. The business has a 50-day moving average price of $29.46 and a 200-day moving average price of $27.51. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 42.89, a PEG ratio of 2.33 and a beta of 2.76.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.01. The business had revenue of $762.10 million during the quarter, compared to analysts’ expectations of $735.94 million. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.25 EPS. Equities research analysts anticipate that Surgery Partners, Inc. will post 0.86 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.